why choose us

First received: March 11, 2024

Clinical Trial: Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Exam

Study Type: OBSERVATIONAL


Official Title: Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

Brief Summary: Study D0817R00081 is a retrospective study using NCID database to assess the safety of Olaparib in Chinese patients with ovarian cancer by examining the incidence, seriousness, and severity of all AEs, including but not limiting to AESIs and SAEs, AEs related to Olaparib, and AEs leading to dose reduction, interruption or discontinuation of Olaparib.The first Olaparib prescription date will be set as the index date.The baseline period is from the patient's first ovarian cancer diagnosis recorded in the…

Read more